DMEK outcome after one year – Results from a large multicenter study in Germany
Acta Ophthalmologica · 2023-03 · 101 (2)
DOI: 10.1111/aos.15257 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, online erschienen am 30.09.2022. Verfasst von Kristina Spaniol und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Düsseldorf, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Descemet Stripping Endothelial Keratoplasty, Fuchs' Endothelial Dystrophy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Descemet membrane endothelial keratoplasty (DMEK) accounts for >50% of all corneal transplants in Germany. So far, no data from such a large multicenter study have been published.
Methods
This retrospective study included 3200 DMEKs at seven departments performed for Fuchs endothelial corneal dystrophy (FECD) or bullous keratopathy (BK). We evaluated best corrected visual acuity (BCVA, logMAR), endothelial cell density (ECD, cells/mm 2 ), minimal corneal thickness (CT, μm), rebubbling‐, primary transplant failure‐ and immune reaction‐rate. Changes over time were evaluated by linear mixed models for repeated measures and correlation with case number by center by weighted linear regression.
Results
For patients without vision‐limiting comorbidities (74% of all analysed eyes, n = 2270), mean BCVA improved from 0.6 ± 0.4 logMAR to 0.2 ± 0.2 logMAR 6 months ( p < 0.001, n = 1441) and 0.1 ± 0.2 logMAR 12 months ( p = 0.001, n = 1402) postoperatively. BK‐ had a worse BCVA compared to FECD‐patients (0.3 ± 0.5 vs. 0.1 ± 0.2 logMAR [ p < 0.001] at 1 year). ECD declined from 2465 ± 259 cells/mm 2 ( n = 2876 preoperatively) to 1587 ± 433 cells/mm 2 after 12 months ( p < 0.001, n = 1237). Mean rebubbling rate was 0.4 ± 0.7/eye. 784 eyes (25%) received at least one rebubbling. More rebubblings correlated with a lower ECD, a worse BCVA, a higher CT, and higher transplant failure and rejection rates ( p < 0.001, p = 0.013 for BCVA at 12 months). A single rebubbling did not influence the BCVA ( p = 0.785). Graft failure rate was 3% ( n = 67), rejection rate 1.5% ( n = 48).
Conclusion
Descemet membrane endothelial keratoplasty increases visual acuity with low transplant failure‐ and rejection‐rates. FECD has a better outcome than BK. Since a quarter of all patients need a rebubbling, this should be included in the informed consent. Remarkably, one rebubbling has no influence on the outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Düsseldorf, Düsseldorf, Germany.
- Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.
- Eye Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
- Department of Ophthalmology, Charité Universitätsmedizin - Berlin, Corporate Member of Freie Universität Berlin, Humbolt-Universität zu Berlin und Berlin Institute of Health, Berlin, Germany.
- Department of Ophthalmology, University Hospital Tübingen, Tübingen, Germany.
ORCID-Profile: Kristina Spaniol, Philip Maier, Anna-Karina Maier, Silvia Schrittenlocher
Zitieren
APA
Spaniol, K., Hellmich, M., Borgardts, K., Girbardt, C., Maier, P., Reinhard, T., Torun, N., Maier, A. K., Thaler, S., Bartz-Schmidt, K. U., Wiedemann, P., Seitz, B., Daas, L., Schrittenlocher, S., Cursiefen, C., Bachmann, B., & Geerling, G. (2023). DMEK outcome after one year – Results from a large multicenter study in Germany. Acta Ophthalmologica, 101(2). https://doi.org/10.1111/aos.15257
Vancouver
Spaniol K, Hellmich M, Borgardts K, Girbardt C, Maier P, Reinhard T, et al. DMEK outcome after one year – Results from a large multicenter study in Germany. Acta Ophthalmologica. 2023;101(2). doi:10.1111/aos.15257
BibTeX
@article{Spaniol2023,
author = {Spaniol, Kristina and Hellmich, Martin and Borgardts, Klara and Girbardt, Christian and Maier, Philip and Reinhard, Thomas and Torun, Necip and Maier, Anna-Karina and Thaler, Sebastian and Bartz-Schmidt, Karl U and Wiedemann, Peter and Seitz, Berthold and Daas, Loay and Schrittenlocher, Silvia and Cursiefen, Claus and Bachmann, Björn and Geerling, Gerd},
title = {DMEK outcome after one year – Results from a large multicenter study in Germany},
journal = {Acta Ophthalmologica},
year = {2023},
volume = {101},
number = {2},
doi = {10.1111/aos.15257}
}
EUVIMED